PapersTrialsTopicsCompoundsCountriesStakeholdersPeopleCoursesEvents
Browse all papers

Latest papers

Long-term efficacy of psilocybin with adjunct psychotherapy in treatment-resistant depressionPsilocybin · Treatment-resistant depressionDrug-drug interactions between psychiatric medications and MDMA or psilocybinMDMA & psilocybin · SafetyAn international mega-analysis of psychedelic drug effects on brain circuit functionCross-compound · NeuroimagingEsketamine in treatment-resistant depression with and without comorbid borderline personalityEsketamine · Treatment-resistant depression

Featured

Road to Access

Science, regulation, and economics on the path to patient access.

01Evidence02Approval03Reimbursement04Delivery05Access—Big Picture
Start the journey
ResultsCompare outcome data across trials and publications.Research SnapshotOne-page overview of trials, participants, papers, and research networks.Clinical GuidelinesTrial-anchored manuals and protocol guidance with competency mapping.Research recapsMonthly evidence summaries with key takeaways.Map of researchLandscape view of trials, compounds, and outcomes.NewsletterWeekly or daily updates on trials, publications, analysis, and more.Research GroupsWorldwide map of psychedelic research centres by region.Research NetworkInteractive co-authorship map of psychedelic researchers.Top papersFind needles in the haystack of psychedelic research per topic.
AskBeta
Pricing
Back to journals
Academic Journal

IEEE Explore

1 Papers Indexed in Blossom

Data updated October 28, 2025

Research Footprint

IEEE Explore has 1 tracked paper indexed in Blossom (2018) from 2 authors, across Depressive Disorders, PTSD and Anxiety Disorders.

Published Papers

Open Accessindividual

Employing Synergistic Interactions of Virtual Reality and Psychedelics in Neuropsychopharmacology

This theory-building paper (2018) proposes the benefits of integrating virtual reality (VR) experiences with psychedelics in order to provide the most effective intervention for certain mental health disorders. The authors discuss three main benefits of integrating these interventions: 1) increases in the efficacy of each individual intervention, 2) increases in specificity and 3) the therapeutic effect can be achieved while using lower doses of a given psychedelic.

Published
March 1, 2018
Journal
IEEE Explore
Authors
Moroz, M., Carhart-Harris, R. L.

Quick Facts

Papers Indexed
1
Publisher
Institute of Electrical and Electronics Engineers
Website
Visit

The intelligence layer for psychedelic research.

Company

  • About
  • Contact
  • Newsletter

Product

  • Feedback
  • Roadmap
  • Changelog
  • API
  • Partners
  • Clinical Guidelines

Legal

  • Privacy
  • Terms

© 2026 Blossom. All rights reserved.